The efficacy and safety of recombinant human thrombopoietin in patients with hematological malgnancies after allogeneic hematopoietic stem cell transplantation

Category Primary study
JournalBlood
Year 2011
This article has no abstract
Epistemonikos ID: f21f7c3e14f9dff0b7e133e306847d4132c1004b
First added on: Feb 05, 2025